Insider Trading Alert - TMO, WDAY And SPLK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, June 5, 2014, 71 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $759.84 to $56,700,000.00.

Highlighted Stocks Traded by Insiders:

Thermo Fisher Scientific (TMO) - FREE Research Report

Harris C Martin, who is Director at Thermo Fisher Scientific, sold 810 shares at $118.27 on June 5, 2014. Following this transaction, the Director owned 3,432 shares meaning that the stake was reduced by 19.09% with the 810-share transaction.

The shares most recently traded at $119.67, up $1.40, or 1.17% since the insider transaction. Historical insider transactions for Thermo Fisher Scientific go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 7,994
  • 24-Week # shares sold: 89,431

The average volume for Thermo Fisher Scientific has been 2.1 million shares per day over the past 30 days. Thermo Fisher Scientific has a market cap of $47.0 billion and is part of the health care sector and health services industry. Shares are up 6.87% year-to-date as of the close of trading on Thursday.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics in the United States and internationally. The stock currently has a dividend yield of 0.51%. The company has a P/E ratio of 30.1. Currently, there are 13 analysts who rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TMO - FREE

TheStreet Quant Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, compelling growth in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Thermo Fisher Scientific Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Jim Cramer: Agilent Technology Has Been One of My Favorites

Secondaries Get Primary Attention; Discerning Market -- Cramer's Top Thoughts

Cramer: Secondary Offerings Get Primary Attention

The Stock Market Is on Fire, Especially in These Sectors: Market Recon

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria